NCT05035680View on ClinicalTrials.gov

Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 14, 2022

Primary Completion Date

March 25, 2023

Study Completion Date

November 25, 2023

Conditions
Influenza
Interventions
BIOLOGICAL

Unadjuvanted seasonal influenza vaccine

Single 0.5 mL IM injection

BIOLOGICAL

SWE adjuvant mixed with unadjuvanted seasonal influenza vaccine shortly before dosing (SWE + QIV)

Single 0.8 mL IM injection

BIOLOGICAL

MF59 adjuvanted seasonal influenza vaccine

Single 0.5 mL IM injection of MF59 adjuvanted seasonal influenza vaccine

Sponsors
All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

Gates Medical Research Institute

OTHER